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It is generally presumed that xeroderma pigmentosum
(XP) patients are extremely sensitive to developing UV
erythema, and that they have a more than 1000-fold
increased skin cancer risk. Recently established mouse
models for XP can be employed to investigate the
mechanism of these increased susceptibilities. In line
with human data, both XPA and XPC knockout mice
have been shown to have an increased susceptibility
to UVB induced squamous cell carcinomas. In XPA
knockouts, nucleotide excision repair of UV induced
DNA photolesions is completely defective (i.e., both
global genome repair and transcription coupled repair
are defective). We determined the strand specific removal
of cyclobutane pyrimidine dimers and pyrimidine [6–4]
pyrimidone photoproducts from the p53 gene in cells
from XPC knockout mice and wild-type littermates.
Sunburn is a UV induced inflammatory reaction that ischaracterized by cutaneous vasodilatation (erythema), andthat can be followed by an increase in vascular permeabilitywith exudation of fluid (edema) in the affected skin. Thepathway leading to sunburn is most commonly thought to
be activated by UV induced DNA damage. The evidence that supports
a linkage between DNA damage and sunburn is that genetic diseases
with defects in the removal of UV photoproducts, such as xeroderma
pigmentosum (XP) and Cockayne syndrome (CS), are accompanied
by increased sensitivity to sunburn (Cleaver and Kraemer, 1989;
Bootsma, 1993). In addition, it has been shown in the opossum
Monodelphis domestica that immediate removal of UV photoproducts by
photoreactivation leads to a suppression of the erythemal response
(Ley, 1985). Furthermore, the wavelengths that are the most effective
in producing UV photolesions (namely, the UVB region) are also the
most effective in producing erythema (Hacham et al, 1991) or edema
(Johnson, 1978). The mechanism that connects DNA damage to the
inflammatory reaction is unclear. UVB induced DNA damage may
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Analogous to human XPC cells, embryonic fibroblasts
from XPC knockout mice are only capable of performing
transcription coupled repair of DNA photolesions. We
show that these XPC knockout mice, in striking contrast
to XPA knockout mice, do not have a lower minimal
erythema/edema dose than their wild-type littermates.
Hence, defective global genome repair appears to lead
to skin cancer susceptibility, but does not influence the
sensitivity to acute effects of UVB radiation, such as
erythema and edema. The latter phenomena thus relate
to the capacity to perform transcription coupled repair,
which suggests that blockage of RNA synthesis is a key
event in the development of UV erythema and edema.
Key words: Cockayne syndrome/cyclobutane pyrimidine dimers/
pyrimidine [6–4] pyrimidone photoproducts/transcription
coupled repair. J Invest Dermatol 110:405–409, 1998
stimulate the synthesis of prostaglandins that activate the inflammatory
mechanism (Naylor, 1997). The pathway from DNA damage to
sunburn may also include different mediators such as histamine
(Hruza and Pentland, 1993), interleukin-1 (Luger and Schwarz, 1995),
interleukin-8, and tumor necrosis factor α (Strickland et al, 1997).
The vascular response to UVB radiation reaches a maximum between
8 and 24 h after exposure of human skin (Van der Leun, 1965;
Andersen et al, 1991), and between 24 and 48 h after exposure of
mouse skin (Trevithick et al, 1992). The difference in the time course
of the response in human and murine skin is probably due to dominance
of either erythema or edema (Cole et al, 1983). Owing to anatomical
differences between man and mouse in the cutaneous vascular density,
the threshold response to UVB radiation of human skin is erythema,
whereas the threshold response to UVB radiation of mouse skin is
edema. The action spectrum for mouse edema at 48 h is very similar
to the action spectrum for human erythema at 24 h, which strongly
suggests that the initial steps are the same (Cole et al, 1983).
The predominant types of UVB induced DNA damage are cyclo-
butane pyrimidine dimers (CPD) and pyrimidine [6–4] pyrimidone
photoproducts (6–4PP), which are removed by the nucleotide excision
repair (NER) system. This complex system (Ma et al, 1995; Wood,
1996) involves the concerted action of multiple proteins to eliminate
lesions from the genome (‘‘global genome repair’’). A specialized
subpathway of NER selectively removes lesions from the transcribed
strand of active genes (Bohr et al, 1985; Mellon et al, 1987), and is
called transcription coupled repair (TCR). The function of TCR is to
alleviate blockage of RNA synthesis caused by the presence of DNA
damage, as only cell lines expressing TCR are capable of restoring UV
inhibited transcription (Ma et al, 1995).
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Mutations in genes that participate in NER cause XP, which is
clinically characterized by photosensitivity and a high incidence of
solar radiation induced skin tumors. The extremely high susceptibility
of XP patients to sunburn suggests that UV induced erythema and
edema are causally related to persistence of UV photoproducts in the
DNA as a consequence of defective NER. Experimental studies on
this relationship are difficult to carry out as XP is a rare disease, and it
consists of at least seven NER defective subgroups (complementation
groups XPA through XPG), each caused by mutations in a different
NER gene, and a NER proficient variant group (Bootsma, 1993; Ma
et al, 1995). Within the same complementation group different XP
patients can vary quantitatively in their responses, as different mutations
in the same gene can lead to different levels of residual enzyme activity.
In addition, experimental in vivo studies on erythema in XP patients
can be considered questionable for obvious ethical reasons.
Recently, mouse models for XP have been established that are very
well suited to studying the relationship between deficiencies in NER
and UV induced erythema/edema and the ultimate tumors. Knockout
mice for the XPA gene (De Vries et al, 1995; Nakane et al, 1995) as
well as for the XPC gene (Sands et al, 1995; Cheo et al, 1997) have
been described. Dysfunctional XPA genes lead to a complete NER
deficiency (i.e., both in global genome repair and in TCR), and
dysfunctional XPC genes lead to a deficiency in global genome repair
only (Venema et al, 1990; Evans et al, 1993). Both XPA and XPC
knockout mice have been shown to have an increased susceptibility
to UVB induced squamous cell carcinomas of the skin (De Vries et al,
1995; Nakane et al, 1995; Sands et al, 1995).
Here we first characterize the NER deficiency in the XPC mice
under study, and then show that these XPC mice are only capable of
removing UV photoproducts from the transcribed strand of the
transcriptionally active p53 gene, i.e., to perform TCR. For an accurate
determination of the sensitivity of mouse skin to UV induced erythema
or edema it is necessary to cross the knockout genotype into a strain
of hairless mice, as it is very difficult to distinguish a minimal effect
on the skin of haired mice that have been shaven. Determination of
the MED in hairless XPA mice has revealed that these mice have an
MED that is about 10 times lower than that of their wild-type
littermates (Berg et al, 1997). Here we report that XPC mice, in
striking contrast to XPA mice, do not have a lower MED than
their wild-type littermates. These results indicate that persistence of
photoproducts in transcriptionally active DNA triggers the pathway
that leads to erythema and edema in the affected skin, whereas
persistence of photoproducts in nontranscribed DNA does not activate
this pathway, but clearly contributes to skin carcinogenesis.
MATERIALS AND METHODS
In the mice used in this experiment, the XPC gene was inactivated by replacing
a fragment of about 4.5 kilobases (spanning exons 3–6) with a replacement
vector followed by homologous recombination in embryonic stem cells (Sands
et al, 1995). This replacement eliminates a coding portion of the mouse gene
corresponding to bases 159 to 1546 of the human XPC cDNA (Legerski and
Peterson, 1992). Embryonic fibroblasts from the XPC knockout mice appeared
to have a decreased survival upon UV irradiation, and the XPC knockout mice
appeared to have an increased susceptibility to UV induced squamous cell
carcinomas of the skin (Sands et al, 1995).
Nucleotide excision repair in XPC mice Mouse embryonic fibroblasts
were isolated from day 13.5 embryos of XPC–/– mice and XPC1/1 littermates
by standard procedures. For analysis of repair of UV induced photolesions,
mouse embryonic fibroblast cells were grown to confluence, rinsed with
phosphate buffered saline buffer, and irradiated with 10 J per m2 or 30 J per
m2 UVC radiation (predominantly 254 nm) for determination of CPD and
6–4PP, respectively. Subsequently, cells were lyzed or incubated in conditioned
medium for various periods of time. Strand specific analysis of CPD and
6–4PP in the p53 gene was performed as described previously (Ruven et al,
1994a; Van Hoffen et al, 1995). Briefly, purified genomic DNA was restricted
with EcoR1 and incubated with the CPD specific enzyme T4 endonuclease V.
For determination of 6–4PP, the restricted DNA was digested with Escherichia
coli Uvr ABC excinuclease, and prior to digestion the CPD were removed
from the DNA by in vitro photoreactivation. Therefore, the DNA was mixed
with photolyase derived from Anacystis nidulans, and exposed to 425 nm light
for 1 h at room temperature. The digested DNA samples were then subjected
Figure 1. XPC mice are proficient in TCR of (A) CPD and (B) 6–4PP.
UV induced CPD and 6–4PP were measured as described in Materials and
Methods in the transcribed and the nontranscribed strand of the p53 gene in
primary mouse embryonic fibroblasts from XPC–/– mice and their wild-type
littermates. ., XPC–/–, nontranscribed strand; m, XPC1/1, nontranscribed
strand; j, XPC –/–, transcribed strand; d, XPC1/1, transcribed strand.
to alkaline gel electrophoresis, transferred to membranes, and hybridized with
strand specific probes recognizing a 16 kb fragment of the p53 gene.
Breeding of hairless XPC mice In order to compare the MED for the
XPC knockout mice with that of their wild-type littermates, the XPC deficient
phenotype was crossed into a hairless mouse strain. Therefore, XPC knockout
mice in a 129/ola-C57Bl/6 background were crossed with albino hairless mice
(HRA/SKH). The offspring was backcrossed with HRA/SKH, and this offspring
was selected for being hairless, for being albino (we selected for animals with
red eyes), and for being heterozygous for the XPC gene. Hairless albino
XPC1/– animals were then intercrossed to generate XPC–/– animals with
heterozygous and wild-type littermates as controls. XPC–/–, XPC1/–, and
XPC1/1 animals were identified by Southern blot analysis of genomic DNA
isolated from the tail tips, as described earlier (Sands et al, 1995).
Determination of acute UVB sensitivity For all three genotypes
(XPC–/–, XPC1/–, and XPC1/1), two male and two female hairless mice
were exposed on the dorsal skin to UVB radiation from a filtered (using a
Schott-WG305 filter) Hanovia Kromayer lamp (dose rate 5 135 J per m2 per
s; 280–400 nm). This is a hand-held lamp that allows short exposures to limited
skin areas by placing the circular port (about 2.5 cm2) of the source in close
contact with the skin (Sontag et al, 1994). For all genotypes male and female
mice were exposed to 4, 8, 16, and 24 s of UV radiation from the Kromayer
lamp. All exposures were given in duplicate on separate mice. The mice were
checked separately by three experienced, but noninformed, observers for
erythema and/or edema at 6, 20, 28, 46, 55, 69, and 127 h after the exposures.
RESULTS
XPC mice only have TCR of CPD and 6–4PP Lack of XPA
leads to a complete NER deficiency, i.e., both in global genome repair
and in TCR (Evans et al, 1993; Ma et al, 1995). To establish the NER
phenotype of the XPC mice used in this experiment, we have measured
strand specific removal of CPD and 6–4PP in the p53 gene. As shown
in Fig 1(A), in both XPC and wild-type mice CPD are efficiently
removed from the transcribed strand (µ90% removal in 24 h), but not
from the nontranscribed strand (,5% removal in 24 h). Figure 1(B)
shows that 6–4PP are efficiently removed from the transcribed strand
in both XPC and wild-type cells (.70% removal in 24 h), and also
from the nontranscribed strand in wild-type cells (µ60% removal in
24 h); however, hardly any removal of 6–4PP from the nontranscribed
strand in XPC cells was found (µ10% removal in 24 h). This NER
phenotype is in agreement with that determined for another XPC
knockout mouse, in which XPC has been inactivated by a smaller
replacement vector (Cheo et al, 1997).
MED not reduced in XPC mice, but strongly reduced in XPA
mice All hairless mice of the three different genotypes (XPC–/–,
XPC1/–, and XPC1/1) showed a clear UV inflammatory response
at 46 h after 16 or 24 s of exposure to the Kromayer lamp. In general,
in the male animals the predominant effect was swelling of the exposed
skin, whereas in the female animals besides swelling a slight redness
was also seen. No macroscopically visible effect was detected on any
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Table I. XPC mice do not have a higher sensitivity to UVB
induced erythema/edema than their heterozygote and wild-
type littermates
6 hb 20 h 28 h 46 h 55 h 69 h 127 h
XPC–/–
4 sa –c – – – – – –
8 s – – – – – – –
16 s – – – 1 1 1 1
24 s – – – 1 1 1 1
XPC1/–
4 s – – – – – – –
8 s – – – – – – –
16 s – – – 1 1 1 6
24 s – – 6 1 1 1 1
XPC1/1
4 s – – – – – – –
8 s – – – – – – –
16 s – – 6 1 1 1 6
24 s – – 6 1 1 1 6
aTimes are exposure times to the Kromayer lamp (dose rate 5 135 J per m2 per s;
280–400 nm).
bTime after the exposure.
c–, no macroscopically visible response; 1, development of clear edema/erythema;
6, variable response between separate animals, or variable judgement of independent
noninformed observers.
Table II. In contrast to XPC mice, XPA mice have a highly
increased sensitivity to UVB induced erythema/edemaa
1 sb 2 s 8 s 16 s
XPA–/–c –d 1 nd nd
XPA1/– nd nd – 1
XPA1/1 nd nd – 1
XPC–/– nd nd – 1
XPC1/– nd nd – 1
XPC1/1 nd nd – 1
aAll mice were an F2 intercross of the parental strains 129/ola-C57Bl6 and HRA/SKH.
bTimes are exposure times to the Kromayer lamp (dose rate 5 135 J per m2 per s;
280–400 nm).
cXPA data from Berg et al (1997).
d–, no macroscopically visible response at any time point; 1, development of edema/
erythema; nd, not done.
of the mice after 4 or 8 s of exposure (see Table I). Hence, the MED
of both the XPC–/– mice and the heterozygote and wild-type
littermates is reached between 8 and 16 s of exposure, which corresponds
to a UV dose between 1080 and 2160 J per m2.
In an earlier experiment we determined the MED for the Kromayer
lamp in XPA knockout mice, which were also breeded as an F2
intercross of the parental strains 129/olaC57Bl6 and HRA/SKH (Berg
et al, 1997). In that study the XPA1/– and the XPA1/1 animals
showed the same response as the mice in this study, i.e., no effect at
8 s and a clear effect at 16 s; however, the XPA–/– animals had their
threshold between 1 and 2 s of exposure (see Table II for comparison).
Hence, mice lacking XPA have an MED that is about a factor 10
lower than that of their wild-type littermates, whereas mice lacking
XPC have an MED that is not lower than that of their wild-type
littermates.
DISCUSSION
UV induced inflammation of the skin (erythema and edema) has been
well documented clinically and histologically; however, the mechanism
that leads from the absorption of UV radiation to the clinical response
remains poorly defined. Persistence of UV photoproducts in the DNA
is likely to be an important step: mice with a complete deficiency in
NER (XPA knockouts; Miyauchi-Hashimoto et al, 1996; Berg et al,
1997) and mice with a deficiency in only TCR (CSB knockouts; Van
der Horst et al, 1997) have an increased sensitivity to UV induced
inflammation of the skin. In this paper we show that mice with a
deficiency solely in global genome repair do not have an increased
sensitivity to UV induced inflammation, i.e., no lower MED than
their wild-type littermates. Hence, the level of sensitivity to UVB
induced erythema and edema appears to be determined by persistence
of photoproducts in transcriptionally active DNA, but not in transcrip-
tionally inactive DNA.
Consistent with human XPC (Van Hoffen et al, 1995), cells from
XPC mice appear deficient in the removal of 6–4PP from the
nontranscribed strand of the p53 gene, but proficient in the removal
of 6–4PP from the transcribed strand of this gene. Also in agreement
with human XPC (Venema et al, 1990; Van Hoffen et al, 1995), cells
from XPC mice appear proficient in the removal of CPD from
transcriptionally active DNA. In contrast with humans, mice are very
inefficient in the removal of CPD from transcriptionally inactive DNA
(Ruven et al, 1993, 1994b). This latter difference between the two
species does not appear to lead to qualitative differences between the
human XPC and the murine XPC phenotype: fibroblasts from human
XPC (Cleaver and Kraemer, 1989) as well as from mouse XPC (Sands
et al, 1995; Cheo et al, 1997) show an increase in sensitivity to killing
by UVC radiation that is of the same order of magnitude. Both XPC
patients (Kraemer et al, 1987; Kondo et al, 1992) and XPC mice (Sands
et al, 1995; Cheo et al, 1997) have an increased susceptibility to UV
induced nonmelanoma skin cancer, and both are prone to pathologic
eye abnormalities, but do not show obvious neurologic abnormalities.
Although the XPC knockout mice used in this study do not have
a lowered UVB induced MED, they do have an increased susceptibility
to UVB induced epidermal hyperplasia and to UVB induced squamous
cell carcinomas (Sands et al, 1995). An increased susceptibility to UVB
induced epidermal hyperplasia and to UVB induced squamous cell
carcinomas has also been reported for CSB knockout mice (defective
in TCR only; Van der Horst et al, 1997) and for XPA knockout mice
(defective in both global genome repair and TCR, De Vries et al,
1995; Nakane et al, 1995). In apparent contrast to erythema and edema,
susceptibility to epidermal hyperplasia and to skin cancer is determined
by accumulation of photoproducts in both transcriptionally active
DNA and transcriptionally inactive DNA.
For reasons already mentioned in the introduction, adequate and
systematic studies on the sensitivity to UV induced erythema in XP
patients are cumbersome: the small number of patients, variations in
response and genetic background, ethically questionable, etc. There
are, however, reports on the erythemal response of XP patients. An
old report by Rottier (1954) describes two XP patients that did not
have an extremely low MED, but these XP patients could at that time
not be assigned to any of the complementation groups. In a report by
Andrews et al (1978), three XP patients were mentioned that did not
suffer from acute sun sensitivity (no experimental determination of
MED was carried out). In later studies XP patients from separate
complementation groups were described. XPA patients are clearly skin
cancer prone and have a low MED (Ichihashi and Fujiwara, 1981;
Kondo et al, 1992). The majority of XPD and XPE patients appear to
have a low MED and are mildly skin cancer prone, i.e., most of them
get skin cancer but at a much later age than XPA patients (Mamada
et al, 1988; Ichihashi et al, 1988; Kondo et al, 1988; Ishii et al, 1991).
Most XPF patients have an MED within the range of healthy humans,
and the ones that get skin cancers also get them at a relatively late age
(Kondo et al, 1989). Nine XPC patients had early skin cancers and
showed MED within the range of healthy humans (Kondo et al,
1992). In this paper we confirm this finding under well controlled
circumstances (i.e., omitting genetic variability between normal as well
as XPC genotypes, differences in history of exposure, pigmentation,
age, etc.) using a mouse model for XPC.
If defective TCR leads to an enhanced susceptibility to erythema,
one would expect patients with disrupted XP or CS genes that are
involved in TCR to have a lowered MED. The CSB gene codes for
a protein that is specifically involved in TCR (Ma et al, 1995), and,
indeed, CSB patients (Norris et al, 1991) and mice (Van der Horst
et al, 1997) have been shown to have a lowered MED. The products
of XPA, XPD, and XPF appear to be involved in TCR (Ma et al,
1995; Wood, 1996), whereas TCR does not require the XPC gene
product (Mu and Sancar, 1997). The role of the XPE gene product in
TCR has not been established yet, but in view of the general
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impairment of NER in XPE cells the defect is likely to affect TCR
as well (Ma et al, 1995). In general, XPA, XPD, and XPE patients
have a low MED, whereas most XPF patients have a normal MED.
Although the MED in most XPF patients is within the normal range,
the development of erythema in many XPF patients is abnormally
delayed, peaking at 48 h or even 72 h after exposure (Kondo et al,
1989). This phenomenon of delayed erythemal reaction has also been
found in XPA patients (Ichihashi and Fujiwara, 1981), in XPD and
XPE patients (Kondo et al, 1989; Kondo et al, 1992), and in CSB
patients (Norris et al, 1991), whereas the tested XPC patients showed
a peak at 24 h after exposure (Kondo et al, 1992). Although there are
reports of XPC patients that have ‘‘sun sensitive’’ skin (e.g., Cleaver
et al, 1981), this condition may well have resulted from accumulated
effects of a series of successive (suberythemal) exposures, and not from
an acute sunburn. We have not been able to find a report of a proven
XPC patient with an objectively assessed deviant MED. In summary,
the available data suggest that disruption of TCR leads to an abnormal
erythemal reaction (lowered treshold and/or delayed development),
whereas specific disruption of global genome repair (as in XPC) does
not affect the erythemal response.
Interestingly, it has recently been shown that cells from XPA and
CSB patients, but not from XPC patients, exhibit UV induced apoptosis
at a considerable lower dose than wild-type cells (Ljungman and
Zhang, 1996). This observation parallels our present finding on
erythemal UV sensitivity in XPA, CSB, and XPC mice. The induction
of apoptosis correlated with the inhibition of RNA synthesis, and,
based on these findings, Ljungman and Zhang propose that blockage
of RNA polymerase at sites of UV photoproducts is the initial step in
the pathway leading to UV induced apoptosis. They, and others
(Yamaizumi and Sugano, 1994), have also shown that nuclear
accumulation of the p53 tumor-suppressor gene product occurs at
lower UV exposure levels in XPA and CSB, but not in XPC, when
compared with normal cells. This suggests that after blockage of RNA
polymerase, nuclear p53 accumulation is an intermediate step towards
the execution of apoptosis.
For UV induced inflammation the first two steps might be the same
as for UV induced apoptosis (i.e., persistence of photoproducts in
transcriptionally active DNA, and blockage of RNA polymerase). It is
very unlikely, however, that nuclear p53 accumulation is also an
important step towards erythema and edema. First, it has been shown
that indomethacin inhibits the development of UVB induced erythema
in human skin without reducing nuclear p53 accumulation (Healy
et al, 1994). Second, our own experiments with hairless p53 knockout
mice did not reveal any influence of absence of p53 on sensitivity to
UVB induced erythema or edema (data not shown), whereas the
experiments of Ziegler and Brash have revealed that being nullizygous
or heterozygous for p53 leads to a marked reduction in UV induced
apoptosis in mouse skin (Ziegler et al, 1994).
Sensitivity to sunburn is generally considered to be an indicator of
skin cancer risk (Naylor, 1997). This study shows that skin cancer
susceptibility is not always paralleled by sensitivity to UV induced
inflammation, which implies that sensitivity to sunburn may not always
be an adequate clinical marker of an individual’s skin cancer risk. This
study also indicates that NER capacity (in particular, the capacity for
global genome repair) may be a better predictor for skin cancer risk
than sensitivity to sunburn. A comparative tumor induction study in
XPC knockout mice versus CSB knockout mice will further unveil
the relative contributions of the NER subpathways global genome
repair and TCR to skin cancer susceptibility.
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